Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea

• Status: Completed
• Trial end date: 2011-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether NPC-01 is effective in the treatment of dysmenorrhea.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nobelpharma
• Treatments: Anti-Inflammatory Agents, Non-Steroidal; Estradiol; Estradiol 17 beta-cypionate; Estradiol 3-benzoate; Estradiol valerate; Ethinyl Estradiol; Norethindrone; Norethindrone acetate; Polyestradiol phosphate

Criteria

Inclusion Criteria:

• dysmenorrhea

Exclusion Criteria:

• severe hepatopathy

• pregnant woman